Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Rheumatoid Arthritis

Free Subscription 02.02.2026 6 Arthritis Res Ther 9 Clin Rheumatol 1 Curr Opin Rheumatol 1 Drugs 1 Eur J Immunol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arthritis Res Ther

1. AGUILAR-COLL M, Molina-Molina M, Robles-Perez A, Roig-Kim M, et al
   Incidence and spectrum of primary respiratory disease throughout the course of rheumatoid arthritis: implications of structured repeated evaluation for detection and risk-factor analysis.
   Arthritis Res Ther. 2026 Jan 23. doi: 10.1186/s13075-026-03736.
   PubMed        
   
   
2. LI S, Zhao Q, Cai X, He X, et al
   Rheumatoid arthritis and gout: a rare combination or overlooked coexistence?
   Arthritis Res Ther. 2026 Jan 26. doi: 10.1186/s13075-026-03746.
   PubMed         Abstract available
   
   
3. MA B, Ma J, Dong X, Kan Y, et al
   Frailty as an indicator of adverse health outcomes in rheumatoid arthritis: a multicenter cross-sectional study.
   Arthritis Res Ther. 2026 Jan 26. doi: 10.1186/s13075-026-03753.
   PubMed        
   
   
4. HUANG X, Lin X, Dai Z, Fang K, et al
   Global variation in the quality of care for rheumatoid arthritis and associated factors.
   Arthritis Res Ther. 2026 Jan 26. doi: 10.1186/s13075-026-03737.
   PubMed         Abstract available
   
   
5. NAVARRETE M, Trivedi K, Klenke C, Zheng Z, et al
   The rheumatoid arthritis citrullinome is enriched in antigenic complement proteins.
   Arthritis Res Ther. 2026 Jan 28. doi: 10.1186/s13075-026-03750.
   PubMed         Abstract available
   
   
6. ZHENG H, Dai Y, Fang J, Lin S, et al
   Association between physical activity and all-cause mortality in rheumatoid arthritis: evidence from NHANES and UK Biobank cohort studies.
   Arthritis Res Ther. 2026 Jan 28. doi: 10.1186/s13075-026-03748.
   PubMed        
   
   

   
   Clin Rheumatol

7. MO Y, Yang W, Li Y, Dai L, et al
   Clinical practice guideline for the treatment of Sjogren's disease through off-label drug use in China (English edition).
   Clin Rheumatol. 2026;45:257-269.
   PubMed         Abstract available
   
   
8. GROENER M, Baker H, Danve A
   VEXAS syndrome presenting with features of Sjogren's disease: a case-based review of VEXAS and autoimmune disease overlap.
   Clin Rheumatol. 2026;45:541-548.
   PubMed         Abstract available
   
   
9. JUNFEI Z, Zhen Z, Fu Q, Meihua G, et al
   Identification of five novel hub genes associated with interstitial lung disease in primary Sjogren's syndrome via transcriptome sequencing.
   Clin Rheumatol. 2026;45:291-307.
   PubMed         Abstract available
   
   
10. HAN F, Gao R, Fan H, Pu J, et al
    Telomere length in leukocyte as biomarker for diagnosis of primary Sjogren's syndrome: a cross-sectional study.
    Clin Rheumatol. 2026;45:309-318.
    PubMed         Abstract available
    
    
11. LEE KA, Kim YH, Kim HS
    Diagnostic concordance and added value of doppler ultrasound and extended histopathologic features in primary Sjogren disease.
    Clin Rheumatol. 2026;45:319-327.
    PubMed         Abstract available
    
    
12. AJDER M, Cansu DU, Colak E, Teke HU, et al
    Etiologic spectrum and early mortality predictors in extreme hyperferritinemia: insights from rheumatology and hematology clinics.
    Clin Rheumatol. 2026;45:531-540.
    PubMed         Abstract available
    
    
13. LIU Z, Yang Y, Liu S, Zhang G, et al
    Initial assessment of blood-brain barrier permeability alterations and associated clinical characteristics in patients with primary Sjogren's syndrome: Insights from DCE-MRI.
    Clin Rheumatol. 2026;45:329-341.
    PubMed         Abstract available
    
    
14. BOURGUIBA R, Bellakhal S, Boudokhane M, Helali W, et al
    Usefulness of salivary gland ultrasonography in Sjogren's syndrome: The Tunisian Experience.
    Clin Rheumatol. 2026;45:251-255.
    PubMed         Abstract available
    
    
15. HAJIALILOU N, Khabbazi A, Hajialilo M, Malek Mahdavi A, et al
    Comparing clinical outcomes of rheumatoid arthritis by onset type: palindromic rheumatism, undifferentiated arthritis, and typical rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 27. doi: 10.1007/s10067-026-07931.
    PubMed         Abstract available
    
    

    
    Curr Opin Rheumatol

16. KLINGEMANN LE, Mikuls TR, England BR
    Epidemiology and outcomes of rheumatoid arthritis.
    Curr Opin Rheumatol. 2026;38:69-75.
    PubMed         Abstract available
    
    

    
    Drugs

17. SEBASTIANI M, Luppi F, Bendstrup E
    Developments and Challenges in Treating Rheumatoid Arthritis-Related Interstitial Lung Disease: From Pathogenesis to Treatment Opportunities.
    Drugs. 2026 Jan 29. doi: 10.1007/s40265-025-02282.
    PubMed         Abstract available
    
    

    
    Eur J Immunol

18. COSTELLO H, Woodcock A, Canavan M
    Restoring Immunological Tolerance via Dendritic Cells in Rheumatoid Arthritis.
    Eur J Immunol. 2026;56:e70136.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.